gavi 5.0 the alliance’s 2021-2025 strategy...the alliance’s 2021-2025 strategy has been...
TRANSCRIPT
Gavi 5.0 – The Alliance’s 2021-2025 strategyAdrien de Chaisemartin, Director, Strategy, Funding & Performance
The Alliance’s 2021-2025 strategy has been developed collaboratively over the past 15 months
2
Q1 Q2 Q3 Q4 Q1 Q2 Q3
2018 2019
March 2018: Board retreat
Contextual analyses and key
themes to be explored
March 2019: Board retreat
Deep dive on key themes,
trade-offs and one-pager
Nov 2018: Board
Guidance on key themes
June 2019: Board
Decision on one
pager
June 2019: Call
one pager and
MICs
Today
Operationalisation
100+ consultations with
partners, countries, CSOs,
manufacturers
Board meeting
26-27 June 2019
The next strategic period will be critical for the Alliance’s new 2030 aspiration
Vis
ion
Introduce and
scale up vaccines
Strengthen health
systems to increase
equity in immunisation
Improve sustainability
of immunisation
programs
Ensure healthy
markets for vaccines
and related products
Go
als
Leaving no-one behind with immunisation
Mis
sio
n To save lives and protect people’s health by increasing coverage
and equitable use of vaccines
Enablers
Set of principles
1 2 3 4
The next strategic period will be critical for the Alliance’s new 2030 aspiration
Vis
ion
Introduce and
scale up vaccines
Strengthen health
systems to increase
equity in immunisation
Improve sustainability
of immunisation
programs
Ensure healthy
markets for vaccines
and related products
Go
als
Leaving no-one behind with immunisation
Mis
sio
n To save lives and protect people’s health by increasing coverage
and equitable use of vaccines
Enablers
Set of principles
1 2 3 4Missed
communities
, first priority
Integrated
Gender
focused
Adaptive,
resilient
Country led,
sustainable
Innovative
Community
owned
Collaborative
accountable
Differentiate
d
Gavi 5.0 high level one-pager: focus on introducing and scaling up new vaccines
Vis
ion
Introduce and
scale up vaccines
Strengthen health
systems to increase
equity in immunisation
Improve sustainability
of immunisation
programs
Ensure healthy
markets for vaccines
and related products
Go
als
Mis
sio
n To save lives and protect people’s health by increasing coverage
and equitable use of vaccines
Enablers
Set of principles
Leaving no-one behind with immunisation
1 2 3 4
Gavi 5.0 high level one-pager: focus on strengthening health systems to increase equity in immunisation
Vis
ion
Introduce and
scale up vaccines
Strengthen health
systems to increase
equity in immunisation
Improve sustainability
of immunisation
programs
Ensure healthy
markets for vaccines
and related products
Go
als
Mis
sio
n To save lives and protect people’s health by increasing coverage
and equitable use of vaccines
Enablers
Set of principles
Leaving no-one behind with immunisation
1 2 3 4
Gavi 5.0 high level one-pager on improving sustainability of immunisation programmes
Vis
ion
Introduce and
scale up vaccines
Strengthen health
systems to increase
equity in immunisation
Improve sustainability
of immunisation
programs
Ensure healthy
markets for vaccines
and related products
Go
als
Mis
sio
n To save lives and protect people’s health by increasing coverage
and equitable use of vaccines
Enablers
Set of principles
Leaving no-one behind with immunisation
1 2 3 4
Gavi 5.0 high level one-pager: focus on ensuring healthy markets for vaccines and related products
Vis
ion
Introduce and
scale up vaccines
Strengthen health
systems to increase
equity in immunisation
Improve sustainability
of immunisation
programs
Ensure healthy
markets for vaccines
and related products
Go
als
Immunisation for all by 2030
Mis
sio
n To save lives and protect people’s health by increasing coverage
and equitable use of vaccines
Enablers
Set of principles
1 2 3 4
Recommendation
The Gavi Alliance Board is requested to:
Approve the framework for the Alliance strategy 2021-2025 (‘strategy
one-pager’) as set out in Doc 06.
9 Board meeting
26-27 June 2019
Gavi 5.0 preliminary forecasted expenditure needs (2021-2025, US$ billion)
4.10.4 0.2
0.3
0.9
IPVCatalytic
vaccines
VIS
3.4
Core vaccines
PEF 1.0
Enabling
support
Ebola
9.5-9.8
Opex 0.7
HSIS
1.7
0.4-0.7
Prov. for
strategic inv.
(incl. Malaria)
Total 2021-25
Board meeting
26-27 June 2019